This activity is expired and is no longer available for CME credit.


Introduction to Emerging Agents

Release Date: 9/7/2016Expiration Date: 9/6/2017
Credit Type: CMENumber of Credits: 0
Content Type: VideoProvider:
Many classes of new agents are being investigated for the treatment of inflammatory bowel disease (IBD). These include selective anti-integrins,sphingosine 1-phosphate receptor modulators, and anti-MAdCAM monoclonal antibodies. In this CME activity, Dr. William Sandborn introduces these and other classes of emerging therapies and discusses how their potential introduction into the clinic might meet currently unmet therapeutic needs.